1Faculty of Medicine, Memorial University of Newfoundland, St. John’s, NL, Canada
2Department of Psychiatry, University of Calgary, Calgary, AB, Canada
3Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada
4Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada
5British Columbia Centre on Substance Use, Vancouver, BC, Canada
Corresponding Author: David Crockford, MD, FRCPC, 1403-29 Street NW, Foothills Medical Centre, Calgary, AB T2N 2T9, Canada, Tel:403-944-1491, fax: 403-270-2093, E-mail: [email protected]
A.B. has received grants to support addiction research training from the National Institutes of Health (NIH) and the National Institute on Drug Abuse (NIDA) through the International Collaborative Addiction Medicine Research Fellowship (R25-DA037756) and the Research in Addiction Medicine Scholars Program (R25-DA033211), respectively. In addition, A.B. is a recipient of the 2020 Friends of Matt Newell Endowment from the University of Calgary Cumming School of Medicine. He also received financial support from a 2020 Research Grant on the Impact of COVID-19 on Psychiatry by the American Psychiatric Association and the American Psychiatric Association Foundation. Currently, A.B. has been awarded doctoral studies research funding from the Canadian Institutes of Health Research (CIHR) Fellowship and the Harley N. Hotchkiss Graduate Scholarship in Neuroscience from the University of Calgary. Furthermore, A.B. has received research funding through the Calgary Health Trust. However, the content is solely the authors’ responsibility and does not represent the official views of NIDA, the University of Calgary, the CIHR, or the Calgary Health Trust.
A.B. receives a small honorarium for teaching undergraduate and postgraduate medical trainees in the Cumming School of Medicine at the University of Calgary. In addition, he is an unpaid member of the Canadian Network for Mood and Anxiety Treatments (CANMAT) editorial committee, the International Society of Addiction Journal Editors (ISAJE), the Canadian Society of Addiction Medicine (CSAM) policy committee, and the Addiction Psychiatry section of the Canadian Psychiatric Association (CPA). A.B. is also an unpaid associate editor of the Canadian Journal of Addiction (CJA) and a mental health educator for TED-Ed, where he receives a small honorarium for supporting online educational content. Finally, A.B. does not report any royalties, licenses, consulting fees, payment or honoraria for lectures or presentations, speaker’s bureaus, manuscript writing, expert testimony, patents, or participation on other boards. The remaining authors declare conflict of interest.
